Pure Global AI
NCT06265194Completed

Effect of EMDR in the Treatment of Fibromyalgia

A Randomized Controlled Trial of Eye Movement Desensitization and Reprocessing (EMDR) in the Treatment of Fibromyalgia
Academy of Therapeutic Sciences, TurkeyClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Fibromyalgia
Drug/Device/Intervention
EMDR
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Academy of Therapeutic Sciences, Turkey
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2015
End date
Mar 01, 2018
Enrollment
79 participants
Primary outcome

Fibromyalgia Impact Questionnaire (FIQ),Pittsburgh Sleep Quality Index (PSQI),Trauma Symptom Checklist-40 (TSC-40)

Summary

The goal of this randomized-controlled study is to investigate the impact of EMDR therapy on
 fibromyalgia symptoms, depression, sleep quality, and traumatic stress in fibromyalgia
 patients.
 
 The main questions it aims to answer are:
 
 - Does EMDR become useful in relieving pain and complaints in fibromyalgia patients?
 
 - Is specific EMDR Fibromyalgia Protocol effective of fibromyalgia patients?
 
 - Does EMDR therapy decrease depression, sleep quality and traumatic stress symptoms of
 individuals with fibromyalgia?

ICD-10 classifications
FibromyalgiaMyalgiaFibrothoraxCervicalgiaEpidemic myalgia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06265194
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06265194 through Pure Global AI's free database. This phase not specified trial is sponsored by Academy of Therapeutic Sciences, Turkey and is currently Completed. The study focuses on Fibromyalgia. Target enrollment is 79 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.